Associated Papers
Translating IBD Genomics into Clinical Practice.
Singh P et al.
Digestive Diseases and Sciences, 2026
Evaluation of FTO polymorphism in 6-mercaptopurine related intolerance in children with acute lymphoblastic leukemia.
Singh M et al.
Cancer Chemotherapy and Pharmacology, 2023
Comprehensive mutations analyses of FTO (fat mass and obesity-associated gene) and their effects on FTO's substrate binding implicated in obesity.
Kumar R et al.
Frontiers in Nutrition, 2022
35923209 (PubMed )
Supplement: Data_Sheet_1.PDF
Comparison of potential inhibitors and targeting fat mass and obesity-associated protein causing diabesity through docking and molecular dynamics strategies.
Kumar SU et al.
Journal of Cellular Biochemistry, 2021
Variants of Lipid-Related Genes in Adult Japanese Patients with Severe Hypertriglyceridemia.
Matsunaga A et al.
Journal of Atherosclerosis and Thrombosis, 2020
An intronic FTO variant rs16952570 confers protection against thiopurine-induced myelotoxicities in multiethnic Asian IBD patients.
Chen S et al.
The Pharmacogenomics Journal, 2020
A coding variant in FTO confers susceptibility to thiopurine-induced leukopenia in East Asian patients with IBD.
Kim HS et al.
Gut, 2017
Genome-Wide Association Studies of Chemotherapeutic Toxicities: Genomics of Inequality.
Mapes B et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2017
Prevalence of loss-of-function FTO mutations in lean and obese individuals.
Meyre D et al.
Diabetes, 2010
Select a paper to view details